STAR 
Strides Arcolab Ltd
How do you think star will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 16
16 outperforms
0 underperforms
Stars: Top Investors who have picked this stock: 3
3 outperforms
0 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 532531 / STAR
- Last traded time
- 2012-05-24 13:17:57
- Last traded on
- NSE
- Intra-day Low / High
- 672.1 / 692.0
- 52w closing Low / High
- 280.5 / 697.7
- Today Volume
- 43,149
- 30d avg Daily Volume
- 253,318
- Market Cap
- INR 4,028.6 cr
- P/E Ratio TTM
- 62.25
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -1.3%
- -0.1%
- 2.6%
- 25.4%
- 82.4%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks
Industry: Pharmaceuticals
| Parameter++ Click on Parameter for definition | Value | Industry Median | Industry Weighted Avg | Parameter ++ | Per Share Value | |
|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 20.2% | 30.9% | Last Closing Price | 677.90 | |
| Core Operating Margin | -4.9% | 6.1% | 12.2% | Book Value per share | 325.42 | |
| EBIT Margin | 38.2% | 10.8% | 41.2% | Long-term Debt per share | 287.41 | |
| Net Profit Margin | 14.6% | 5.1% | 30.3% | Enterprise Value per share | 1,219.75 | |
| Adj Net Profit Margin | 6.2% | 5.0% | 14.4% | Net Cash per share | 11.09 | |
| Return on Assets | 2.8% | 5.5% | 21.2% | Cash from Operations per share | 13.02 | |
| Return on Capital Employed | 7.4% | 12.2% | 30.9% | Free Cashflow per share | 3.09 | |
| Return on Equity | 5.2% | 9.2% | 30.7% | Sales per share | 116.63 | |
| Asset Turnover | 0.19 | 0.97 | 0.70 | Total income per share | 166.97 | |
| Cash Return (FCFF/EV) | 1.9% | -40.8% | 0.3% | PAT per share | 17.02 | |
| Adj Price-to-Earnings TTM ** | 62.25 | 26.00 | -- | Adj PAT per share | 7.21 | |
| Adj Price-to-Earnings | 129.29 | 17.07 | 25.53 | |||
| Price-to-Book | 2.87 | 1.22 | 3.73 | |||
| Price-to-FCF | 301.54 | -- | -849.98 | |||
| EV / EBITDA | 25.36 | 9.34 | 9.26 | |||
| Price-to-Sales | 7.99 | 0.74 | 3.69 | |||
| Financial Leverage | 1.88 | 1.46 | 1.45 | |||
| Interest Coverage | 1.86 | 4.51 | 14.57 | |||
| Debt to MarketCap | 0.31 | 0.33 | 0.12 | |||
| 1y Dividend Yield | 0.2% | 0.2% | 1.0% | |||
| 1y Dividend Payout | 29.4% | 3.4% | 24.3% | |||
| 3y Dividend Yield | 0.2% | 0.6% | 0.8% | |||
| 3y Dividend Payout | 28.8% | 9.4% | 25.0% | |||
| 3y Sales Growth CAGR | -5.3% | 13.7% | 12.9% | |||
| 3y Earnings Growth CAGR | 128.9% | 0.6% | 39.7% |
++ All values calculated using standalone 2010 Financial Results (unless otherwise mentioned)
** From last 4 quarterly results
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
STAR IN THE NEWS
- Apr-27 11:00 Strides Arcolab's director resigns
- Apr-27 8:01 Strides Arcolab reports net loss of Rs 28.16 crore in the March 2012 quarter
- Apr-19 14:33 Strides Arcolab receives USFDA approval for Cisplatin Injection
- Apr-19 9:18 Strides Arcolab allots equity shares
- Apr-18 12:09 Strides Arcolab to announce financial results
- Apr-11 12:05 Strides Arcolab receives USFDA approval for Vancomycin Oral Capsules
- Mar-20 11:44 Strides Arcolab allots equity shares
- Mar-13 10:13 Strides Arcolab allots equity shares
- Mar-02 17:12 Strides Arcolab allots equity shares
- Feb-27 15:43 Strides Arcolab net profit rises 134.49% in the December 2011 quarter
TOP BLOGS
- The business of Indian politics
by AJAY SHAH
(Recommendations: 7) - Mid Week Update
by Nishit_Vadhavkar
(Recommendations: 5) - Advice for – Thursday, May 24, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - At last the Government bites the bullet
by ASHOKSHARMA
(Recommendations: 8) - The problem with historical returns
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 8) - Nifty – RSI at sub 30. Highly Oversold – Bottoming out in next few sessions
by NOORESH MERANI
(Recommendations: 9) - Follow up: Gujarat reclaim & rubber products ltd
by ROHIT CHAUHAN
(Recommendations: 9) - Negative news drags the markets down
by Nishit_Vadhavkar
(Recommendations: 7) - Option strategy worked will in such unpredictable market
by ASHOKSHARMA
(Recommendations: 8) - Sensex- Technical Outlook and Trading Levels, 8 April 2012
by D_Sathiamoorthy
(Recommendations: 5)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |